Tranexamic Acid Spinal Fusion Study
Condition: Postoperative blood loss
Full Study Name
Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery (IRB no. 51597)
The purpose of this study is to evaluate the investigational use of a drug called tranexamic acid (TXA) during spinal fusion surgery. Significant blood loss is common in patients undergoing complex spinal fusion surgery. Researchers aim to determine whether TXA will reduce the amount of bleeding after surgery and may help to reduce the rate of blood transfusions in these patients.
Participants will be randomly assigned to one of two study groups. The first group will receive the study drug, and the second group will receive a placebo (inactive substance).